Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UFUR and Thalidomide in Advanced HCC
NCT00384800Phase 2Unknown
- Sponsor
- Far Eastern Memorial Hospital
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of thalidomide and tegafur + uracil in hepatocellular carcinoma (HCC), sponsored by Far Eastern Memorial Hospital. Status: unknown.
02
Drugs
thalidomidetegafur + uracil
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00384800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384800.